ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0216

The Rejected Manuscripts: Its Quality, Its Fate, and Empirical-based Suggestions for Improvement

Aldo Barajas-Ochoa1, Antonio Cisneros-Barrios2 and Cesar Ramos-Remus3, 1Rutgers New Jersey Medical School., Richmond, VA, 2Universidad de Guadalajara, Guadalajara, Mexico, 3Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico

Meeting: ACR Convergence 2022

Keywords: Data Management, Decision analysis, education, medical

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: To assess the quality and performance of manuscripts previously rejected by a rheumatology-focused journal.

Methods: This was a cross-sectional, audit-type study of manuscripts submitted to Clinical Rheumatology-Springer Nature (CLRH) and rejected by one of the associate editors in 2019. We used a 36-item instrument to assess quality (5-point ordinal scale, 1 being worst). Performance variables included whether a rejected manuscript was published in another PubMed-listed journal, impact factor of the publishing journal (Scimago), number of citations (Web of Science), and social media attention (Altmetrics). Exploratory variables included authors’ past publications, use of reporting guidelines (e.g. CONSORT, STROBE), and text structure. Exploratory variables were assessed using non-parametric tests.

Results: In total, 165 manuscripts were rejected. Reporting guidelines were used in only five (4%) manuscripts. The mean overall quality rating was 2.48 ± 0.73, with 54% of manuscripts rated 2. Between 40% and 80% of manuscripts were rated < 3 on crucial items, such as objectives, setting, study participants, and limitations. Over a 26-month follow-up, 79 (48%) rejected manuscripts were published in other journals, mostly with lower impact factors; 70% of these had at least one citation, compared with 90.5% for manuscripts published in CLRH. Altmetrics was significantly lower for manuscripts published elsewhere than for those published in CLRH. As for text structure, the methods and results sections were shorter and the discussion longer than suggested. The corresponding authors’ past experience and text structure were not associated with quality or acceptance.

Conclusion: Research report quality is an area for improvement, mainly for items critical to explaining the research and findings. Use of reporting guidelines should be encouraged by journals.


Disclosures: A. Barajas-Ochoa, None; A. Cisneros-Barrios, None; C. Ramos-Remus, None.

To cite this abstract in AMA style:

Barajas-Ochoa A, Cisneros-Barrios A, Ramos-Remus C. The Rejected Manuscripts: Its Quality, Its Fate, and Empirical-based Suggestions for Improvement [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/the-rejected-manuscripts-its-quality-its-fate-and-empirical-based-suggestions-for-improvement/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-rejected-manuscripts-its-quality-its-fate-and-empirical-based-suggestions-for-improvement/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology